Royalty Pharma $2 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Oesterreichische Kontrollbank $1.5 billion notes offering
The 3.75% notes are due 2030
Klarna Group $1.37 billion IPO
We are advising Klarna on its IPO
ING Groep $1.5 billion Additional Tier 1 capital securities offering
The SEC-registered offering consisted of Additional Tier 1 contingent convertible securities
Pepkor Holdings ZAR 26.6 billion secondary offering
The offering represented approximately 28% of Pepkor’s issued share capital
Prosus $12 billion program update and €750 million notes offering
The investment-grade notes are due 2035
Kyivstar Group de-SPAC transaction
The transaction resulted in Ukraine’s leading digital operator becoming a U.S.-listed public company
Deutsche Bank $2 billion notes offerings
The offerings included fixed-to-floating-rate and floating-rate eligible liabilities notes
eDreams ODIGEO €560 million refinancing
We advised eDreams ODIGEO on its senior secured high-yield notes offering and refinancing
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction